EssilorLuxottica to Acquire PUcore’s Ophthalmic Lens Materials Division

EssilorLuxottica has announced a strategic agreement to acquire the ophthalmic lens materials division of PUcore, a South Korea–based company known for its role in the development, manufacturing, and commercialization of monomers used in high index ophthalmic lenses. This move reinforces EssilorLuxottica’s long-term strategy to expand its technological capabilities and strengthen its upstream integration in the lens manufacturing value chain.

Strategic Assets Included in the Acquisition

Under the terms of the agreement, EssilorLuxottica will acquire all assets and entities of PUcore that are directly involved in the monomer business. This includes:

       • A research and development unit

       • A materials production facility

       • A sales office located in the Republic of Korea

       • An intellectual property portfolio encompassing product formulations and production processes related to high index ophthalmic materials

The financial details of the transaction have not been disclosed.

Executive Commentary on the Acquisition

Francesco Milleri, Chairman and CEO of EssilorLuxottica, and Paul du Saillant, Deputy CEO, emphasized the strategic significance of this acquisition in a company statement:

“We are happy to welcome PUcore’s optical division and its talented teams into our Group. In line with our commitment to elevating standards in the research, development and manufacturing of ophthalmic lenses, this addition will allow us to widen our portfolio of patents, technologies and know-how and extend our expertise upstream in the value chain."

They further noted that by improving the formulation and production of high index monomers, the company aims to enhance performance and sustainability throughout the ophthalmic lens industry’s supply and manufacturing processes.

The transaction is expected to close by the end of 2025, subject to regulatory approvals and other customary closing conditions.